The outcome of tilted distal implants immediately loaded under screw-retained cross-arch prostheses. A 5-year retrospective cohort study
2024-01-01 Giordano, F.; Di Spirito, F.; Acerra, A.; Rupe, A.; Cirigliano, G.; Caggiano, M.
Bcl-2 family inhibitors sensitize human cancer models to therapy
2023-01-01 Valentini, Elisabetta; Di Martile, Marta; Brignone, Matteo; Di Caprio, Marica; Manni, Isabella; Chiappa, Michela; Sergio, Ilaria; Chiacchiarini, Martina; Bazzichetto, Chiara; Conciatori, Fabiana; D’Aguanno, Simona; D’Angelo, Carmen; Ragno, Rino; Russillo, Michelangelo; Colotti, Gianni; Marchesi, Francesco; Bellone, Maria Laura; Dal Piaz, Fabrizio; Felli, Maria Pia; Damia, Giovanna; Del Bufalo, Donatella
Broadening specificity and enhancing cytotoxicity of adoptive T cells for nasopharyngeal carcinoma immunotherapy
2016-01-01 Fae, D. A.; Martorelli, D.; Mastorci, K.; Muraro, E.; Dal Col, J.; Franchin, G.; Barzan, L.; Comaro, E.; Vaccher, E.; Rosato, A.; Dolcetti, R.
Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes
2008-01-01 Terrin, L.; Dal Col, J.; Rampazzo, E.; Zancai, P.; Pedrotti, M.; Ammirabile, G.; Bergamin, S.; Rizzo, S.; Dolcetti, R.; De Rossi, A.
Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma
2008-01-01 Dal Col, J.; Zancai, P.; Terrin, L.; Guidoboni, M.; Ponzoni, M.; Pavan, A.; Spina, M.; Bergamin, S.; Rizzo, S.; Tirelli, U.; De Rossi, A.; Doglioni, C.; Dolcetti, R.
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells
2011-01-01 Trotta, R.; Ciarlariello, D.; Dal Col, J.; Mao, H.; Chen, L.; Briercheck, E.; Yu, J.; Zhang, J.; Perrotti, D.; Caligiuri, M. A.
hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: A basis for new therapies
2013-01-01 Giunco, S.; Dolcetti, R.; Keppel, S.; Celeghin, A.; Indraccolo, S.; Dal Col, J.; Mastorci, K.; De Rossi, A.
The Role of Migration for Workplace Safety in Italy
2024-01-01 Aldieri, L.; Nese, A.; Vinci, C. P.
Analyzing the factors affecting university contributions to achieving the sustainable development goals in European Union countries
2024-01-01 Raimo, Nicola; Nicolò, Giuseppe; L'Abate, Vitiana; Vitolla, Filippo
Telerehabilitation: A Solution for Patients After Hip Fracture?
2024-01-01 Bramanti, Alessia; Ciurleo, Rossella; Vecchione, Carmine; Turolla, Andrea; Piramide, Noemi; Ciccarelli, Michele; Piramide, Erica; Marina Garofano, And
A Set of Possible Markers for Monitoring Heart Failure and Cognitive Impairment Associated: A Review of Literature from the Past 5 Years
2024-01-01 Pagano, Maria; Corallo, Francesco; D’Aleo, Piercataldo; Duca, Antonio; Bramanti, Placido; Bramanti, Alessia; Cappadona, Irene
Lanthanum(III)hydroxide Nanoparticles and Polyethyleneimine-Functionalized Graphene Quantum Dot Nanocomposites in Photosensitive Silicon Heterojunctions
2024-01-01 Anter, Aslıhan; Orhan, Elif; Ulusoy, Murat; Polat, Barış; Yıldız, Mustafa; Kumar, Arun; Di Bartolomeo, Antonio; Faella, Enver; Passacantando, Maurizio; Bi, Jinshun
Breathing mode of a quantum droplet in a quasi-one-dimensional dipolar Bose gas
2024-01-01 Orignac, E.; De Palo, S.; Salasnich, L.; Citro, R.
The PP2A inhibitor SET regulates natural killer cell IFN-γ production
2007-01-01 Trotta, R.; Ciarlariello, D.; Dal Col, J.; Allard II, J.; Neviani, P.; Santhanam, R.; Mao, H.; Becknell, B.; Yu, J.; Ferketich, A. K.; Thomas, B.; Modi, A.; Blaser, B. W.; Perrotti, D.; Caligiuri, M. A.
NFATc2 is a potential therapeutic target in human melanoma
2012-01-01 Perotti, V.; Baldassari, P.; Bersani, I.; Molla, A.; Vegetti, C.; Tassi, E.; Dal Col, J.; Dolcetti, R.; Anichini, A.; Mortarini, R.
Epstein-Barr virus and telomerase: From cell immortalization to therapy
2014-01-01 Dolcetti, R.; Giunco, S.; Dal Col, J.; Celeghin, A.; Mastorci, K.; De Rossi, A.
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting
2015-01-01 Martorelli, D.; Muraro, E.; Mastorci, K.; Dal Col, J.; Fae, D. A.; Furlan, C.; Giagulli, C.; Caccuri, F.; Rusnati, M.; Fiorentini, S.; Carbone, A.; Caruso, A.; Dolcetti, R.
hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: Implications for EBV-driven lymphomagenesis
2007-01-01 Terrin, L.; Dolcetti, R.; Corradini, I.; Indraccolo, S.; Dal Col, J.; Bertorelle, R.; Bonaldi, L.; Esposito, G.; De Rossi, A.
TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and antibody-dependent cellular cytotoxicity in human NK cells
2008-01-01 Trotta, R.; Dal Col, J.; Yu, J.; Ciarlariello, D.; Thomas, B.; Zhang, X.; Allard II, J.; Wei, M.; Mao, H.; Byrd, J. C.; Perrotti, D.; Caligiuri, M. A.
GSK-3β inhibition: At the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma
2008-01-01 Dal Col, J.; Dolcetti, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The outcome of tilted distal implants immediately loaded under screw-retained cross-arch prostheses. A 5-year retrospective cohort study | 1-gen-2024 | Giordano, F.; Di Spirito, F.; Acerra, A.; Rupe, A.; Cirigliano, G.; Caggiano, M. | |
| Bcl-2 family inhibitors sensitize human cancer models to therapy | 1-gen-2023 | Valentini, Elisabetta; Di Martile, Marta; Brignone, Matteo; Di Caprio, Marica; Manni, Isabella; Chiappa, Michela; Sergio, Ilaria; Chiacchiarini, Martina; Bazzichetto, Chiara; Conciatori, Fabiana; D’Aguanno, Simona; D’Angelo, Carmen; Ragno, Rino; Russillo, Michelangelo; Colotti, Gianni; Marchesi, Francesco; Bellone, Maria Laura; Dal Piaz, Fabrizio; Felli, Maria Pia; Damia, Giovanna; Del Bufalo, Donatella | |
| Broadening specificity and enhancing cytotoxicity of adoptive T cells for nasopharyngeal carcinoma immunotherapy | 1-gen-2016 | Fae, D. A.; Martorelli, D.; Mastorci, K.; Muraro, E.; Dal Col, J.; Franchin, G.; Barzan, L.; Comaro, E.; Vaccher, E.; Rosato, A.; Dolcetti, R. | |
| Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes | 1-gen-2008 | Terrin, L.; Dal Col, J.; Rampazzo, E.; Zancai, P.; Pedrotti, M.; Ammirabile, G.; Bergamin, S.; Rizzo, S.; Dolcetti, R.; De Rossi, A. | |
| Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma | 1-gen-2008 | Dal Col, J.; Zancai, P.; Terrin, L.; Guidoboni, M.; Ponzoni, M.; Pavan, A.; Spina, M.; Bergamin, S.; Rizzo, S.; Tirelli, U.; De Rossi, A.; Doglioni, C.; Dolcetti, R. | |
| The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells | 1-gen-2011 | Trotta, R.; Ciarlariello, D.; Dal Col, J.; Mao, H.; Chen, L.; Briercheck, E.; Yu, J.; Zhang, J.; Perrotti, D.; Caligiuri, M. A. | |
| hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: A basis for new therapies | 1-gen-2013 | Giunco, S.; Dolcetti, R.; Keppel, S.; Celeghin, A.; Indraccolo, S.; Dal Col, J.; Mastorci, K.; De Rossi, A. | |
| The Role of Migration for Workplace Safety in Italy | 1-gen-2024 | Aldieri, L.; Nese, A.; Vinci, C. P. | |
| Analyzing the factors affecting university contributions to achieving the sustainable development goals in European Union countries | 1-gen-2024 | Raimo, Nicola; Nicolò, Giuseppe; L'Abate, Vitiana; Vitolla, Filippo | |
| Telerehabilitation: A Solution for Patients After Hip Fracture? | 1-gen-2024 | Bramanti, Alessia; Ciurleo, Rossella; Vecchione, Carmine; Turolla, Andrea; Piramide, Noemi; Ciccarelli, Michele; Piramide, Erica; Marina Garofano, And | |
| A Set of Possible Markers for Monitoring Heart Failure and Cognitive Impairment Associated: A Review of Literature from the Past 5 Years | 1-gen-2024 | Pagano, Maria; Corallo, Francesco; D’Aleo, Piercataldo; Duca, Antonio; Bramanti, Placido; Bramanti, Alessia; Cappadona, Irene | |
| Lanthanum(III)hydroxide Nanoparticles and Polyethyleneimine-Functionalized Graphene Quantum Dot Nanocomposites in Photosensitive Silicon Heterojunctions | 1-gen-2024 | Anter, Aslıhan; Orhan, Elif; Ulusoy, Murat; Polat, Barış; Yıldız, Mustafa; Kumar, Arun; Di Bartolomeo, Antonio; Faella, Enver; Passacantando, Maurizio; Bi, Jinshun | |
| Breathing mode of a quantum droplet in a quasi-one-dimensional dipolar Bose gas | 1-gen-2024 | Orignac, E.; De Palo, S.; Salasnich, L.; Citro, R. | |
| The PP2A inhibitor SET regulates natural killer cell IFN-γ production | 1-gen-2007 | Trotta, R.; Ciarlariello, D.; Dal Col, J.; Allard II, J.; Neviani, P.; Santhanam, R.; Mao, H.; Becknell, B.; Yu, J.; Ferketich, A. K.; Thomas, B.; Modi, A.; Blaser, B. W.; Perrotti, D.; Caligiuri, M. A. | |
| NFATc2 is a potential therapeutic target in human melanoma | 1-gen-2012 | Perotti, V.; Baldassari, P.; Bersani, I.; Molla, A.; Vegetti, C.; Tassi, E.; Dal Col, J.; Dolcetti, R.; Anichini, A.; Mortarini, R. | |
| Epstein-Barr virus and telomerase: From cell immortalization to therapy | 1-gen-2014 | Dolcetti, R.; Giunco, S.; Dal Col, J.; Celeghin, A.; Mastorci, K.; De Rossi, A. | |
| A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting | 1-gen-2015 | Martorelli, D.; Muraro, E.; Mastorci, K.; Dal Col, J.; Fae, D. A.; Furlan, C.; Giagulli, C.; Caccuri, F.; Rusnati, M.; Fiorentini, S.; Carbone, A.; Caruso, A.; Dolcetti, R. | |
| hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: Implications for EBV-driven lymphomagenesis | 1-gen-2007 | Terrin, L.; Dolcetti, R.; Corradini, I.; Indraccolo, S.; Dal Col, J.; Bertorelle, R.; Bonaldi, L.; Esposito, G.; De Rossi, A. | |
| TGF-β utilizes SMAD3 to inhibit CD16-mediated IFN-γ production and antibody-dependent cellular cytotoxicity in human NK cells | 1-gen-2008 | Trotta, R.; Dal Col, J.; Yu, J.; Ciarlariello, D.; Thomas, B.; Zhang, X.; Allard II, J.; Wei, M.; Mao, H.; Byrd, J. C.; Perrotti, D.; Caligiuri, M. A. | |
| GSK-3β inhibition: At the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma | 1-gen-2008 | Dal Col, J.; Dolcetti, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista13923
Data di pubblicazione
- In corso di stampa10
- 2020 - 20246071
- 2010 - 20196560
- 2000 - 2009859
- 1990 - 1999302
- 1980 - 1989109
- 1971 - 197912
Editore
- PACINI EDITORE, VIA DELLA GHERARD...4
- Lancet Limited:42 Bedford Square,...2
- [Washington, DC,: American Chemic...1
- American Institute of Physics:2 H...1
- Blackwell Science Limited:PO Box ...1
- Cambridge University Press1
- CERN1
- CINet1
- IEEE / Institute of Electrical an...1
- INFORMATION AND COMPUTATION1
Rivista
- PHYSICS LETTERS. SECTION B256
- THE EUROPEAN PHYSICAL JOURNAL. C,...148
- CHEMICAL ENGINEERING TRANSACTIONS123
- MOLECULES118
- JOURNAL OF NATURAL PRODUCTS99
- SCIENTIFIC REPORTS95
- SUSTAINABILITY90
- APPLIED SCIENCES87
- PHYSICAL REVIEW LETTERS81
- JOURNAL OF HIGH ENERGY PHYSICS79
Keyword
- Humans788
- Female350
- Male340
- Middle Aged220
- COVID-19189
- Aged183
- Adult177
- Animals128
- Italy120
- Medicine (all)120
Lingua
- eng12490
- ita291
- spa44
- enm20
- fre17
- por4
- ger3
- rus2
- ain1
- chi1
Accesso al fulltext
- no fulltext13392
- open338
- partially open106
- reserved86
- mixed1